Informex 2013: Bright outlook for US API manufacturing

Drug companies looking for fast turnaround and strong intellectual property (IP) protection are moving away from low-cost emerging market firms—lifting prospects for US-based producers of active pharmaceutical ingredients (APIs) producers, according to attendees of Informex, held earlier this month at Anaheim, CA....

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers